Inflammatory determinants of asthma severity: Mediator and cellular changes in bronchoalveolar lavage fluid of patients with severe asthma

Journal of Allergy and Clinical Immunology

Volumn 98, Issue 5 SUPPL., 1996, Pages

  Virchow Jr , J Christian ^a   Kroegel, Claus ^a   Walker, Christoph ^a   Matthys, Heinrich ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Allergic asthma; Bronchoalveolar lavage; Cytokines; Intrinsic asthma; T helper lymphocytes; T suppressor lymphocytes

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8;

ASTHMA; BRONCHUS REACTIVITY; CONFERENCE PAPER; DISEASE SEVERITY; HELPER CELL; HUMAN; LUNG LAVAGE; PRIORITY JOURNAL; SUPPRESSOR CELL; T LYMPHOCYTE;

ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; HUMANS; SEVERITY OF ILLNESS INDEX;

EID: 0029949570     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(96)80126-6     Document Type: Article

References (23)

1. Virchow JC, Jr., Öhling A, Boer L, Hansel TT, Werner P, Matthys H, et al. Pulmonary function, activated T cells, peripheral blood eosinophilia, and serum activity for eosinophil survival in vitro: a longitudinal study in bronchial asthma. J Allergy Clin Immunol 1994;94:204-9.
2. International consensus report on diagnosis and treatment of asthma. National Heart, Lung, and Blood Institute, Publication No. 92-3091. Eur Respir J 1992;5:601-41.
3. Taylor KJ, Luksza AR. Peripheral blood eosinophil counts and bronchial responsiveness. Thorax 1987;42:452-6.
4. Walker C, Kaegi MK, Braun P, Blaser K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991;88:935-42.
5. Lacoste J-Y, Bousquet J, Chanez P, Van Vyve T, Simony-Lafontaine J, Lequeu N, et al. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol 1993;92:537-48.
6. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow J-C Jr. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992;146:109-15.
7. Walker C, Bauer W, Braun RK, Menz G, Braun P, Schwarz F, et al. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 1994;150:1038-48.
8. Virchow JC Jr., Kroegel C, Luttmann W, Häfner D, Kortsik C, Werner P, et al. T cell activation markers and cytokine concentrations in patients with chronic bronchitis and bronchial asthma [abstract]. Am J Respir Crit Care Med 1994;149:A954.
9. van Vyve T, Chanez P, Bousquet J, Lacoste J-Y, Michel FB, Godard P. Safety of bronchoalveolar lavage and bronchial biopsies in patients with asthma of variable severity. Am Rev Respir Dis 1992;146:116-21.
10. Rackemann FM. A working classification of asthma. Am J Med 1947;3:601-6.
11. Kroegel C, Virchow JC Jr., Walker C. Asthma [letter]. N Engl J Med 1993;328:1639-40.
12. Mattoil S, Mattoso VL, Soloperto M, Allegra L, Fasoli A. Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. J Allergy Clin Immunol 1991;87:794-802.
13. Broide DH, Lotz M, Cuomo A, Coburn DA, Federman EC, Wasserman SI. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992;89:958-67.
14. Virchow JC Jr., Walker C, Häfner D, Kortsik C, Werner P, Matthys H, et al. T-cells and cytokines in BAL after segmental allergen provocation in atopic asthma. Am J Respir Crit Care Med 1995;151:960-8.
15. Marini M, Avoni E, Hollemborg J, Mattoil S. Cytokine mRNA profile and cell activation in bronchoalveolar lavage fluid from nonatopic patients wtih symptomatic asthma. Chest 1992;102:661-9.
16. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, et al. Evidence for a predominant '91Th2-type' bronchoalveolar lavage T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
17. Casale TB, Wood D, Richerson HB, Zehr B, Zavala D, Hunninghake GW. Direct evidence of a role for mast cells in the pathogenesis of antigen-induced bronchoconstriction. J Clin Invest 1978;80:1507-11.
18. Wong DTW, Weller PF, Galli SJ, Elovic A, Rand TH, Gallagher GT, et al. Human eosinophils express transforming growth factor α. J Exp Med 1990;172:673-81.
19. Bradding P, Feather IH, Howarth PH, Mueller R, Roberts JA, Britten K, et al. Interleukin 4 is localized to and released by human mast cells. J Exp Med 1992;176:1381-6.
20. Wodnar-Filipowicz A, Hausser CH, Moroni C. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature 1989;339:150-2.
21. De Monchy JG, Kaufmann HF, Venge P, Koëter GH, Jansen HM, Sluiter HJ, et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985;131:373-6.
22. Walker C, Virchow J-C Jr., Bruijnzeel PLB, Blaser K. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol 1991;146:1829-35.
23. Valenta R, Duchene M, Pettenburger K, Sillaber C, Valent P, Bettelheim P. et al. Identification of profilin as a novel allergen; IgE autoreactivity in sensitized individuals. Science 1991;253:557-60.